BioCentury
ARTICLE | Clinical News

Immunoscore Colon regulatory update

January 13, 2017 8:52 PM UTC

HalioDx launched its Immunoscore Colon diagnostic assay in Europe as an aid to assess prognosis of primary colon cancer. The product, which has CE Mark approval, is an in vitro diagnostic that measure...

BCIQ Company Profiles

HalioDx S.A.S.